Abstract: Method for loading various molecules into plant-derived nanovesicles, comprising the following steps: a. suspending the isolated nanovesicles in a phosphate buffered saline; b. analyzing the suspended nanovesicles with a technique called “Nanoparticle Tracking Analysis” using a “Nanosight” for the evaluation of concentration and size distribution; c. re-suspending the nanovesicles in phosphate buffered saline; d. transferring the nanovesicles to sterile means; e. adding the fluorescent chemical to be loaded; f. treating the nanovesicles in the sterile means to facilitate the entry of the molecule to be loaded through their cell membrane; g. transferring the nanovesicles loaded with the desired molecule into ultra¬centrifuge tubes; h. re-suspending the pellet containing the nanovesicles in phosphate buffered saline and storing the supernatant obtained from the ultracentrifugation as a control for subsequent analysis; i. re-suspending the nanovesicles in phosphate buffered saline and proceed with testing.

Abstract: The invention according to the present document discloses a device 1 configured for conveying a toxic aerosol from a drug contained in a syringe (S) or in a vial (F) toward a suction pipe, comprising a cylindrical hollow element comprising an inner space configured for accommodating a syringe so that the inner walls of said space slidingly adhere to the outer walls of the syringe barrel, provided with a proximal end 2.10 which includes an opening 2.6 configured in such a way as to allow the insertion of a syringe barrel, and a flange configured for accommodating a syringe flange, and a distal end 2.11 which includes an opening 2.7 configured in such a way as to allow the cone, fitting, and needle of said syringe to pass through, and a cap configured for being connected to said cylindrical hollow element present in two configurations, one suitable for administering a drug and another suitable for taking a drug from a vial, in particular a drug potentially releasing a toxic aerosol.

Abstract: The present invention relates to isolated ligands of anti-Mullerian hormone marked so as to be directly detectable by means of magnetic resonance imaging in the endometriosic lesions. In particular, such ligands can be used in a method for diagnosing in vivo endometriosis wherein said method comprises a passage of localizing and/or evaluating the entity of the endometriosic lesions in a patient.

Abstract: The present invention relates to isolated ligands of anti-Mullerian hormone marked so as to be directly detectable by means of magnetic resonance imaging in the endometriosic lesions. In particular, such ligands can be used in a method for diagnosing in vivo endometriosis wherein said method comprises a passage of localizing and/or evaluating the entity of the endometriosic lesions in a patient.

Abstract: The present description relates to an in vitro method for the diagnosis of endometriosis, an in vitro method for the monitoring of endometriosis and a kit for the diagnosis of endometriosis and/or for the monitoring of endometriosis in a subject.